» Articles » PMID: 39203531

Pathogenesis, Diagnosis, and Treatment of Infectious Rhinosinusitis

Overview
Journal Microorganisms
Specialty Microbiology
Date 2024 Aug 29
PMID 39203531
Authors
Affiliations
Soon will be listed here.
Abstract

Rhinosinusitis is a common inflammatory disease of the sinonasal mucosa and paranasal sinuses. The pathogenesis of rhinosinusitis involves a variety of factors, including genetics, nasal microbiota status, infection, and environmental influences. Pathogenic microorganisms, including viruses, bacteria, and fungi, have been proven to target the cilia and/or epithelial cells of ciliated airways, which results in the impairment of mucociliary clearance, leading to epithelial cell apoptosis and the loss of epithelial barrier integrity and immune dysregulation, thereby facilitating infection. However, the mechanisms employed by pathogenic microorganisms in rhinosinusitis remain unclear. Therefore, this review describes the types of common pathogenic microorganisms that cause rhinosinusitis, including human rhinovirus, respiratory syncytial virus, , , , etc. The damage of mucosal cilium clearance and epithelial barrier caused by surface proteins or secreted virulence factors are summarized in detail. In addition, the specific inflammatory response, mainly Type 1 immune responses (Th1) and Type 2 immune responses (Th2), induced by the entry of pathogens into the body is discussed. The conventional treatment of infectious sinusitis and emerging treatment methods including nanotechnology are also discussed in order to improve the current understanding of the types of microorganisms that cause rhinosinusitis and to help effectively select surgical and/or therapeutic interventions for precise and personalized treatment.

References
1.
Alford M, Choi K, Trimble M, Masoudi H, Kalsi P, Pletzer D . Murine Model of Sinusitis Infection for Screening Antimicrobial and Immunomodulatory Therapies. Front Cell Infect Microbiol. 2021; 11:621081. PMC: 7994591. DOI: 10.3389/fcimb.2021.621081. View

2.
Ooi E, Wormald P, Carney A, James C, Tan L . Surfactant protein d expression in chronic rhinosinusitis patients and immune responses in vitro to Aspergillus and alternaria in a nasal explant model. Laryngoscope. 2007; 117(1):51-7. DOI: 10.1097/01.mlg.0000243196.75418.6f. View

3.
Xie Y, Zhou X, Zhang J, Yu H, Song Z . Immunomodulatory responses of differentially polarized macrophages to fungal infections. Int Immunopharmacol. 2022; 111:109089. DOI: 10.1016/j.intimp.2022.109089. View

4.
Porter P, Lim D, Maskatia Z, Mak G, Tsai C, Citardi M . Airway surface mycosis in chronic TH2-associated airway disease. J Allergy Clin Immunol. 2014; 134(2):325-31. PMC: 4119856. DOI: 10.1016/j.jaci.2014.04.028. View

5.
Chirkova T, Lin S, Oomens A, Gaston K, Boyoglu-Barnum S, Meng J . CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells. J Gen Virol. 2015; 96(9):2543-2556. PMC: 4635495. DOI: 10.1099/vir.0.000218. View